Stian Foss

1.9k total citations
32 papers, 1.2k citations indexed

About

Stian Foss is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Stian Foss has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Immunology. Recurrent topics in Stian Foss's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (9 papers) and interferon and immune responses (7 papers). Stian Foss is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (9 papers) and interferon and immune responses (7 papers). Stian Foss collaborates with scholars based in Norway, United Kingdom and United States. Stian Foss's co-authors include Jan Terje Andersen, Inger Sandlie, Leo C. James, Jens Harder, Maria Bottermann, Algirdas Grevys, Ruth Watkinson, Udo Heyen, Marina Vaysburd and Malin Bern and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Stian Foss

32 papers receiving 1.2k citations

Peers

Countries citing papers authored by Stian Foss

Since Specialization

Citations

This map shows the geographic impact of Stian Foss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stian Foss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stian Foss more than expected).

Fields of papers citing papers by Stian Foss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stian Foss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stian Foss. The network helps show where Stian Foss may publish in the future.

Co-authorship network of co-authors of Stian Foss

This figure shows the co-authorship network connecting the top 25 collaborators of Stian Foss. A scholar is included among the top collaborators of Stian Foss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stian Foss. Stian Foss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life 2025 ·PNAS Nexus ·(unknown), (unknown), (unknown), Stian Foss, J.H. Marco Jansen, (unknown), Mitchell Evers, Jeannette Nilsen, Karli R. Reiding, J Damen, Renate Burger, Algirdas Grevys, Bjørn Dalhus, Thomas Valerius, Inger Sandlie, Jeanette H.W. Leusen, Jan Terje Andersen	3
2	Antibody blockade of Jagged1 attenuates choroidal neovascularization 2023 ·Nature Communications ·Torleif Tollefsrud Gjølberg, (unknown), (unknown), (unknown), Nicola Bassi, Panagiotis Christopoulos, Malin Bern, Stian Foss, Goran Petrovski, Morten C. Moe, Guttorm Haraldsen, Johanna Hol Fosse, Bjørn Steen Skålhegg, Jan Terje Andersen, Eirik Sundlisæter	9
3	Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties 2023 ·International Journal of Retina and Vitreous ·Øystein Kalsnes Jørstad, Stian Foss, Torleif Tollefsrud Gjølberg, (unknown), (unknown), (unknown), (unknown), (unknown), Morten C. Moe, Jan Terje Andersen	6
4	Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge 2022 ·Science Immunology ·Stian Foss, (unknown), Maria Bottermann, Ruth Watkinson, (unknown), (unknown), Terje E. Michaelsen, Inger Sandlie, Leo C. James, Jan Terje Andersen	20
5	Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life 2022 ·Communications Biology ·Torleif Tollefsrud Gjølberg, Rahel Frick, (unknown), Stian Foss, Algirdas Grevys, Lene S. Høydahl, Øystein Kalsnes Jørstad, Tilman Schlothauer, Inger Sandlie, Morten C. Moe, Jan Terje Andersen	14
6	Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life 2022 ·iScience ·Algirdas Grevys, Rahel Frick, (unknown), Karine Flem‐Karlsen, Jeannette Nilsen, Stian Foss, Kine Marita Knudsen Sand, Thomas Emrich, Jens A. A. Fischer, Victor Greiff, Inger Sandlie, Tilman Schlothauer, Jan Terje Andersen	35
7	FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex–driven autoimmunity 2020 ·The Journal of Experimental Medicine ·Jonathan J. Hubbard, Michał Pyzik, Timo Räth, Lisa K. Kozicky, Kine Marita Knudsen Sand, Amit Gandhi, Algirdas Grevys, Stian Foss, (unknown), Jonathan N. Glickman, Edda Fiebiger, Derry C. Roopenian, Inger Sandlie, Jan Terje Andersen, Laura M. Sly, Kristi Baker, Richard S. Blumberg	34
8	A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes 2019 ·Scientific Reports ·(unknown), Torleif Tollefsrud Gjølberg, Stian Foss, (unknown), (unknown), Yvonne Andersson, Øystein Kalsnes Jørstad, Morten C. Moe, Jan Terje Andersen	23
9	Complement C4 Prevents Viral Infection through Capsid Inactivation 2019 ·Cell Host & Microbe ·Maria Bottermann, Stian Foss, Sarah Caddy, Dean Clift, Laurens M. van Tienen, Marina Vaysburd, (unknown), (unknown), Jessica Clark, (unknown), (unknown), (unknown), (unknown), Inger Sandlie, Jan Terje Andersen, Leo C. James	52
10	Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease 2018 ·Gastroenterology ·Lene S. Høydahl, Lisa Richter, Rahel Frick, Omri Snir, Kristin Støen Gunnarsen, Ole J.B. Landsverk, Rasmus Iversen, Jeliazko R. Jeliazkov, Jeffrey J. Gray, Elin Bergseng, Stian Foss, Shuo‐Wang Qiao, Knut E. A. Lundin, Jørgen Jahnsen, Frode L. Jahnsen, Inger Sandlie, Ludvig M. Sollid, Geir Åge Løset	61
11	TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination 2018 ·Proceedings of the National Academy of Sciences ·Maria Bottermann, Stian Foss, Laurens M. van Tienen, Marina Vaysburd, (unknown), (unknown), Jessica Clark, (unknown), (unknown), (unknown), (unknown), Greg Slodkowicz, Edward Hutchinson, Patrycja Kozik, Jan Terje Andersen, Leo C. James	46
12	A human endothelial cell-based recycling assay for screening of FcRn targeted molecules 2018 ·Nature Communications ·Algirdas Grevys, Jeannette Nilsen, Kine Marita Knudsen Sand, Muluneh Bekele Daba, Inger Øynebråten, Malin Bern, (unknown), Stian Foss, Tilman Schlothauer, Terje E. Michaelsen, Gregory J. Christianson, Derry C. Roopenian, Richard S. Blumberg, Inger Sandlie, Jan Terje Andersen	64
13	Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties 2018 ·Scientific Reports ·(unknown), Øystein Kalsnes Jørstad, Algirdas Grevys, Stian Foss, Morten C. Moe, Jan Terje Andersen	24
14	TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity 2016 ·The Journal of Immunology ·Stian Foss, Ruth Watkinson, Algirdas Grevys, (unknown), Malin Bern, Lene S. Høydahl, Bjørn Dalhus, Terje E. Michaelsen, Inger Sandlie, Leo C. James, Jan Terje Andersen	34
15	Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization 2015 ·Journal of Controlled Release ·Stian Foss, Algirdas Grevys, Kine Marita Knudsen Sand, Malin Bern, Patricia A. Blundell, Terje E. Michaelsen, Richard J. Pleass, Inger Sandlie, Jan Terje Andersen	23
16	Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies 2014 ·Journal of Biological Chemistry ·Kine Marita Knudsen Sand, Bjørn Dalhus, Gregory J. Christianson, Malin Bern, Stian Foss, Jason Cameron, Darrell Sleep, Magnar Bjørås, Derry C. Roopenian, Inger Sandlie, Jan Terje Andersen	37
17	Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn 2014 ·Immunobiology ·(unknown), Grethe Bergseth, Stian Foss, (unknown), Tobias Gedde‐Dahl, Jan Holt, Dorte Christiansen, Corinna Lau, Ole‐Lars Brekke, Elina Armstrong, Vedran Stefanović, Jan Terje Andersen, Inger Sandlie, Tom Eirik Mollnes	86
18	Selection of Nanobodies that Target Human Neonatal Fc Receptor 2013 ·Scientific Reports ·Jan Terje Andersen, María González-Pajuelo, Stian Foss, Ole J.B. Landsverk, (unknown), (unknown), Hans J. de Haard, Michael Saunders, Peter Vanlandschoot, Inger Sandlie	8
19	Anti-carcinoembryonic Antigen Single-chain Variable Fragment Antibody Variants Bind Mouse and Human Neonatal Fc Receptor with Different Affinities That Reveal Distinct Cross-species Differences in Serum Half-life 2012 ·Journal of Biological Chemistry ·Jan Terje Andersen, Stian Foss, Vania Kenanova, Tove Olafsen, (unknown), Derry C. Roopenian, Anna M. Wu, Inger Sandlie	28
20	Thauera linaloolentis sp. nov. and Thauera terpenica sp. nov., Isolated on Oxygen-containing Monoterpenes (Linalool, Menthol, and Eucalyptol and Nitrate 1998 ·Systematic and Applied Microbiology ·Stian Foss, Jens Harder	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact